Basics Lifevantage Corporation Lifevantage Corp is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products including Protandim, LifeVantage TrueScience and Canine Health. IPO Date: May 1, 1994 Sector: Consumer Staples Industry: Personal Products Market Cap: $152.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.64% Avg Daily Range (30 D): $0.37 | 2.86% Avg Daily Range (90 D): $0.34 | 2.65% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 80 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.62M Avg Inst. Trade (90 D): $2.43M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.53M Avg Closing Trade (30 D): $.62M Avg Closing Trade (90 D): $6.31M Avg Closing Volume: 317.53K     News Sep 3, 2025 @ 9:00 PM LifeVantage Announces Acquisition of LoveBiome, Ex... Source: Lifevantage Corporation Oct 29, 2024 @ 8:06 PM LifeVantage Declares Quarterly Dividend Source: Globe Newswire Oct 14, 2024 @ 12:00 PM LifeVantage Introduces the MindBody GLP-1 Systemâ... Source: N/A May 23, 2024 @ 12:00 PM LifeVantage To Participate in Upcoming Investor Co... Source: LifeVantage Corporation May 2, 2024 @ 8:06 PM LifeVantage Declares Quarterly Dividend Source: LifeVantage Corporation Financials   TTM Q4 2025 FY 2025 Basic EPS $.8 $.16 $.8 Diluted EPS $.75 $.15 $.75 Revenue $ 228.53M $ 55.11M $ 228.53M Gross Profit $ 183.67M $ 44.05M $ 183.67M Net Income / Loss $ 9.81M $ 1.96M $ 9.81M Operating Income / Loss $ 12.2M $ 2.15M $ 12.2M Cost of Revenue $ 44.86M $ 11.07M $ 44.86M Net Cash Flow $ 3.32M $ -2.27M $ 3.32M PE Ratio 15.12     Splits Oct 19, 2015:   1:7 Oct 05, 2004:   1:68